MYOF Identified as Novel Glioblastoma Therapeutic Target, Enabling Drug Discovery
Glioblastoma remains one of the deadliest brain cancers, notorious for its resistance to standard therapy and its ability to adapt ...
Glioblastoma remains one of the deadliest brain cancers, notorious for its resistance to standard therapy and its ability to adapt ...
In the relentless pursuit to understand the metabolic adaptations enabling glioblastoma cells to survive in harsh tumor microenvironments, recent groundbreaking ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine